A protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions

Journal of Allergy and Clinical Immunology

Volumn 129, Issue 2, 2012, Pages 443-447

  Patil, Sarita U ^a   Long, Aidan A ^a   Ling, Morris ^a   Wilson, Michael T ^a   Hesterberg, Paul ^a   Wong, Johnson T ^a   Banerji, Aleena ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Carboplatin; desensitization; drug allergy; hypersensitivity; skin testing

Indexed keywords

CARBOPLATIN; HISTAMINE; SODIUM CHLORIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED STUDY; DESENSITIZATION; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; MALE; MEDICAL HISTORY; PATIENT CARE; PATIENT CODING; PATIENT SAFETY; PRICK TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPEAT PROCEDURE; RISK ASSESSMENT; SKIN ALLERGY; SKIN TEST; TIME;

CARBOPLATIN; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK; SKIN TESTS;

EID: 84856443686     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.10.010     Document Type: Article

References (14)

1. A. Polyzos, N. Tsavaris, C. Kosmas, T. Arnaouti, N. Kalahanis, and C. Tsigris Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience Oncology 61 2001 129 133
2. M. Markman, A. Kennedy, K. Webster, P. Elson, G. Peterson, and B. Kulp Clinical features of hypersensitivity reactions to carboplatin J Clin Oncol 17 1999 1141
3. J.B. Robinson, D. Singh, D.C. Bodurka-Bevers, J.T. Wharton, D.M. Gershenson, and J.K. Wolf Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies Gynecol Oncol 82 2001 550 558
4. H.H. Windom, W.P. McGuire 3rd, R.G. Hamilton, and N.F. Adkinson Jr. Anaphylaxis to carboplatin - a new platinum chemotherapeutic agent J Allergy Clin Immunol 90 1992 681 683
5. A.K. Sood, M.S. Gelder, S.W. Huang, and L.S. Morgan Anaphylaxis to carboplatin following multiple previous uncomplicated courses Gynecol Oncol 57 1995 131 132
6. M.C. Castells, N.M. Tennant, D.E. Sloane, F.I. Hsu, N.A. Barrett, and D.I. Hong Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases J Allergy Clin Immunol 122 2008 574 580
7. P.G. Rose, N. Fusco, M. Smrekar, K. Mossbruger, and M. Rodriguez Successful administration of carboplatin in patients with clinically documented carboplatin hypersensitivity Gynecol Oncol 89 2003 429 433
8. V. Leguy-Seguin, G. Jolimoy, B. Coudert, C. Pernot, S. Dalac, and P. Vabres Diagnostic and predictive value of skin testing in platinum salt hypersensitivity J Allergy Clin Immunol 119 2007 726 730
9. K.M. Zanotti, L.A. Rybicki, A.W. Kennedy, J.L. Belinson, K.D. Webster, and B. Kulp Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy J Clin Oncol 19 2001 3126 3129
10. R. Gomez, P. Harter, H.J. Luck, A. Traut, S. Kommoss, and M. Kandel Carboplatin hypersensitivity: does introduction of skin test and desensitization reliably predict and avoid the problem? A prospective single-center study Int J Gynecol Cancer 19 2009 1284 1287
11. M. Markman, K. Zanotti, G. Peterson, B. Kulp, K. Webster, and J. Belinson Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity J Clin Oncol 21 2003 4611 4614
12. P.E. Hesterberg, A. Banerji, E. Oren, R.T. Penson, C.N. Krasner, and M.V. Seiden Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management J Allergy Clin Immunol 123 2009 1262 1267 e1
13. R.G. Breslow, J. Caiado, and M.C. Castells Acetylsalicylic acid and montelukast block mast cell mediator-related symptoms during rapid desensitization Ann Allergy Asthma Immunol 102 2009 155 160
14. C.W. Lee, U.A. Matulonis, and M.C. Castells Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions Gynecol Oncol 95 2004 370 376